Publications by authors named "Camilla Amato"

Article Synopsis
  • * The combination of Ruxolitinib (a JAK inhibitor) and Resminostat (an HDAC inhibitor) has shown promising results in reducing tumor cell migration and angiogenesis in experimental models of cutaneous T-cell lymphoma (CTCL).
  • * Treatment with these inhibitors resulted in a significant decrease in the migration of CTCL cells and blood vessel formation, indicating their potential as effective anti-angiogenic therapies for improving treatment strategies in CTCL.
View Article and Find Full Text PDF

ERK1/2 mitogen-activated protein kinases (ERK) are key regulators of basic cellular processes, including proliferation, survival, and migration. Upon phosphorylation, ERK becomes activated and a portion of it dimerizes. The importance of ERK activation in specific cellular events is generally well documented, but the role played by dimerization is largely unknown.

View Article and Find Full Text PDF

Berberine (BBR) is known for its antitumor activity and photosensitizer properties in anti-cancer photodynamic therapy (PDT), and it has previously been favorably assayed against glioblastoma multiforme (GBM)-derived cells. In this work, two BBR hydrophobic salts, dodecyl sulfate (S) and laurate (L), have been encapsulated in PLGA-based nanoparticles (NPs), chitosan-coated by the addition of chitosan oleate in the preparation. NPs were also further functionalized with folic acid.

View Article and Find Full Text PDF

Photodynamic therapy (PDT) is a promising anticancer strategy based on the light energy stimulation of photosensitizers (PS) molecules within a malignant cell. Among a multitude of recently challenged PS, Rose bengal (RB) has been already reported as an inducer of cytotoxicity in different tumor cells. However, RB displays a low penetration capability across cell membranes.

View Article and Find Full Text PDF